Monogenic susceptibility to infectious pathogens

• Název práce v češtině: Monogenně podmíněné vnímavosti k infekčním patogenům
• Název v anglickém jazyce: Monogenic susceptibility to infectious pathogens
• Klíčová slova: vrozené poruchy imunity, infekce, Candida, mycobacterium, SARS-CoV-2, IL-12, IL-23, IFNγ, MSMD, Th17, STAT1, IL-6, PIMS-TS, MIS-C
• Klíčová slova anglicky: inborn errors of immunity, infections, Candida, mycobacterium, SARS-CoV-2, IL-12, IL-23, IFNγ, MSMD, Th17, STAT1, IL-6, PIMS-TS, MIS-C
• Akademický rok vypsání: 2017/2018
• Typ práce: disertační práce
• Jazyk práce: angličtina
• Ústav: Ústav imunologie (13-722)
• Vedoucí / školitel: prof. MUDr. Anna Šedivá, DSc.
• Řešitel: skrytý - zadáno a potvrzeno stud. odd.
• Datum přihlášení: 07.10.2017
• Datum zadání: 07.10.2017
• Datum potvrzení stud. oddělením: 07.10.2017
• Datum a čas obhajoby: 08.03.2023 14:00
• Datum odevzdání elektronické podoby: 03.01.2023
• Datum odevzdání tištěné podoby: 06.10.2022
• Datum proběhlé obhajoby: 08.03.2023
• Oponenti: prof. MUDr. Martina Koziar Vašáková, Ph.D.
• Konzultanti: RNDr. Zuzana Paračková, Ph.D.

Seznam odborné literatury

1. Abadom, Tochukwu Raphael, Adrian D Smith, Stefano Tempia, Shabir A Madhi, Cheryl Cohen, and Adam L Cohen. 2016. “Risk Factors Associated with Hospitalisation for Influenza-Associated Severe Acute Respiratory Illness in South Africa: A Case-Population Study.” Vaccine 34 (46): 5649–55.
2. Achkar, Jacqueline M, John Chan, and Arturo Casadevall. 2015. “B Cells and Antibodies in the Defense against Mycobacterium Tuberculosis Infection.” Immunological Reviews 264 (1): 167–81.
3. Agarwal, Sarika, Viviana P Ferreira, Claudio Cortes, Michael K Pangburn, Peter A Rice, and Sanjay Ram. 2010. “An Evaluation of the Role of Properdin in Alternative Pathway Activation on Neisseria Meningitidis and Neisseria Gonorrhoeae.” The Journal of Immunology 185 (1): 507–16.
4. Alandijany, Thamir. 2019. “Host Intrinsic and Innate Intracellular Immunity During Herpes Simplex Virus Type 1 (HSV-1) Infection.” Frontiers in Microbiology 10 (November): 1–20.
5. Alberts B, Johnson A, Lewis J. 2002. “The Adaptive Immune System.” In Molecular Biology of the Cell., 4th ed.
6. Andersen, Line Lykke, Nanna Mørk, Line S Reinert, Emil Kofod-Olsen, Ryo Narita, Sofie E Jørgensen, Kristian A Skipper, et al. 2015. “Functional IRF3 Deficiency in a Patient with Herpes Simplex Encephalitis.” Journal of Experimental Medicine 212 (9): 1371–79.
7. Arduino, Paolo G, and Stephen R Porter. 2008. “Herpes Simplex Virus Type 1 Infection: Overview on Relevant Clinico-Pathological Features*.” Journal of Oral Pathology & Medicine 37 (2): 107–21.
8. Arenzana-Seisdedos, Fernando, and Marc Parmentier. 2006. “Genetics of Resistance to HIV Infection: Role of Co-Receptors and Co-Receptor Ligands.” Seminars in Immunology 18 (6): 387–403.
9. Asano, Takaki, Bertrand Boisson, Fanny Onodi, Daniela Matuozzo, Marcela Moncada-Velez, Majistor Raj Luxman Maglorius Renkilaraj, Peng Zhang, et al. 2021. “X-Linked Recessive TLR7 Deficiency in ~1% of Men under 60 Years Old with Life-Threatening COVID-19.” Science Immunology 6 (62): eabl4348.
10. Averbuch, Diana, Ariane Chapgier, Stéphanie Boisson-Dupuis, Jean-Laurent Casanova, and Dan Engelhard. 2011. “The Clinical Spectrum Of Patients With Deficiency Of Signal Transducer And Activator Of Transcription-1.” The Pediatric Infectious Disease Journal 30 (4).
11. Báez-Gutierrez, Nerea, and Héctor Rodríguez-Ramallo. 2021. “Candidiasis in Patients Treated with Interleukin-17 Inhibitors.” Indian Journal of Pharmacology 53 (3): 244–45.
12. Bastard, Paul, Lindsey B. Rosen, Qian Zhang, Eleftherios Michailidis, Hans Heinrich Hoffmann, Yu Zhang, Karim Dorgham, et al. 2020. “Autoantibodies against Type I IFNs in Patients with Life-Threatening COVID-19.” Science 370 (6515).
13. Bennett, Craig L, Jacinda Christie, Fred Ramsdell, Mary E Brunkow, Polly J Ferguson, Luke Whitesell, Thaddeus E Kelly, Frank T Saulsbury, Phillip F Chance, and Hans D Ochs. 2001. “The Immune Dysregulation, Polyendocrinopathy, Enteropathy, X-Linked Syndrome (IPEX) Is Caused by Mutations of FOXP3.” Nature Genetics 27 (1): 20–21.
14. Béziat, Vivien, Juan Li, Jian-Xin Lin, Cindy S Ma, Peng Li, Aziz Bousfiha, Isabelle Pellier, et al. 2018. “A Recessive Form of Hyper-IgE Syndrome by Disruption of ZNF341-Dependent STAT3 Transcription and Activity.” Science Immunology 3 (24): eaat4956.
15. Bhattad, Sagar, Jeeson Unni, and Sonny Varkey. 2021. “MSMD in a 3-Generation Multiplex Kindred Due to Autosomal Dominant STAT1 Deficiency.” Journal of Clinical Immunology 41 (1): 259–61.
16. Bieniasz, Paul D. 2004. “Intrinsic Immunity: A Front-Line Defense against Viral Attack.” Nature Immunology 5 (11): 1109–15.
17. Bilbo, Staci D, Carina L Block, Jessica L Bolton, Richa Hanamsagar, and Phuong K Tran. 2018. “Beyond Infection - Maternal Immune Activation by Environmental Factors, Microglial Development, and Relevance for Autism Spectrum Disorders.” Experimental Neurology 299 (Pt A): 241–51.
18. Bloomfield, Markéta, Havránková, Eva, Houšťková, Hana, Kabíček Pavle, Křepela, Karel, Šedivá Anna, and Bustamante Jacinta. 2016. "Vrozená Vnímavost k Mykobakteriálním Onemocněním.” Česko-slovenská Pediatrie 71 (7-8): 340-344.
19. Bloomfield, Markéta, Kanderová, Veronika, Paračková, Zuzana, Vrabcová, Petra, Svatoň, Michael, Froňková, Eva, Fejtková Martina et al. 2018. “Utility of Ruxolitinib in a Child with Chronic Mucocutaneous Candidiasis Caused by a Novel STAT1 Gain-of-Function Mutation.” Journal of Clinical Immunology 38 (5): 589–601.
20. Bloos, Frank, Jürgen Held, Peter Schlattmann, Nicole Brillinger, Oliver Kurzai, Oliver A Cornely, and Daniel Thomas-Rüddel. 2018. “(1,3)-β-D-Glucan-Based Diagnosis of Invasive Candida Infection versus Culture-Based Diagnosis in Patients with Sepsis and with an Increased Risk of Invasive Candida Infection (CandiSep): Study Protocol for a Randomized Controlled Trial.” Trials 19 (1): 472.
21. Bluyssen, HansA.R., and David E Levy. 1997. “Stat2 Is a Transcriptional Activator That Requires Sequence-Specific Contacts Provided by Stat1 and P48 for Stable Interaction with DNA *.” Journal of Biological Chemistry 272 (7): 4600–4605.
22. Bohlson, Suzanne, Strasser Jennifer A., Bower Jacquelyn J., and Schorey Jeffrey S. 2001. “Role of Complement in Mycobacterium Avium Pathogenesis: In Vivo and In Vitro Analyses of the Host Response to Infection in the Absence of Complement Component C3.” Infection and Immunity 69 (12): 7729–35.
23. Boisson-Dupuis, Stephanie, Xiao Fei Kong, Satoshi Okada, Sophie Cypowyj, Anne Puel, Laurent Abel, and Jean Laurent Casanova. 2012. “Inborn Errors of Human STAT1: Allelic Heterogeneity Governs the Diversity of Immunological and Infectious Phenotypes.” Current Opinion in Immunology.
24. Braubach, Peter, Torsten Lippmann, Didier Raoult, Jean Christophe Lagier, Ioannis Anagnostopoulos, Steffen Zender, Florian Peter Länger, Hans Heinrich Kreipe, Mark Philipp Kühnel, and Danny Jonigk. 2017. “Fluorescence in Situ Hybridization for Diagnosis of Whipple’s Disease in Formalin-Fixed Paraffin-Embedded Tissue.” Frontiers in Medicine 4 (JUN).
25. Brown, Kevin E, Jonathan R Hibbs, Giorgio Gallinella, Stacie M Anderson, Elton D Lehman, Peggy McCarthy, and Neal S Young. 1994. “Resistance to Parvovirus B19 Infection Due to Lack of Virus Receptor (Erythrocyte P Antigen).” New England Journal of Medicine 330 (17): 1192–96.
26. Browne, Sarah K, Peter D Burbelo, Ploenchan Chetchotisakd, Yupin Suputtamongkol, Sasisopin Kiertiburanakul, Pamela A Shaw, Jennifer L Kirk, et al. 2012. “Adult-Onset Immunodeficiency in Thailand and Taiwan.” New England Journal of Medicine 367 (8): 725–34.
27. Bruton, Ogden. 1952. “Agammaglobulinemia.” Pediatrics 9 (6): 722–28.
28. Bucciol, Giorgia, Leen Moens, Barbara Bosch, Xavier Bossuyt, Jean Laurent Casanova, Anne Puel, and Isabelle Meyts. 2019. “Lessons Learned from the Study of Human Inborn Errors of Innate Immunity.” Journal of Allergy and Clinical Immunology.
29. Bustamante, Jacinta. 2020. “Mendelian Susceptibility to Mycobacterial Disease: Recent Discoveries.” Human Genetics 139 (6): 993–1000.
30. Bustamante, Jacinta, Stéphanie Boisson-Dupuis, Laurent Abel, and Jean-Laurent Casanova. 2014. “Mendelian Susceptibility to Mycobacterial Disease: Genetic, Immunological, and Clinical Features of Inborn Errors of IFN-γ Immunity.” Seminars in Immunology 26 (6): 454–70.
31. Casanova, Jean-Laurent, and Laurent Abel. 2004. “The Human Model: A Genetic Dissection of Immunity to Infection in Natural Conditions.” Nature Reviews Immunology 4 (1): 55–66.
32. Casanova, Jean-Laurent and Abel, Laurent. 2005. “Inborn Errors of Immunity to Infection : The Rule Rather than the Exception .” Journal of Experimental Medicine 202 (2): 197–201.
33. Casanova, Jean-Laurent, Mary Ellen Conley, Stephen J Seligman, Laurent Abel, and Luigi D Notarangelo. 2014. “Guidelines for Genetic Studies in Single Patients: Lessons from Primary Immunodeficiencies.” Journal of Experimental Medicine 211 (11): 2137–49.
34. Casanova, Jean Laurent, Claire Fieschi, Jacinta Bustamante, Janine Reichenbach, Natasha Remus, Horst Von Bernuth, and Capucine Picard. 2005. “From Idiopathic Infectious Diseases to Novel Primary Immunodeficiencies.” Journal of Allergy and Clinical Immunology 116 (2): 426–30.
35. Chantrain, C F, A Bruwier, B Brichard, V Largent, A Chapgier, J Feinberg, J-L Casanova, J-P Stalens, and C Vermylen. 2006. “Successful Hematopoietic Stem Cell Transplantation in a Child with Active Disseminated Mycobacterium Fortuitum Infection and Interferon-γ Receptor 1 Deficiency.” Bone Marrow Transplantation 38 (1): 75–76.
36. Chapman, Stephen J, and Adrian V S Hill. 2012. “Human Genetic Susceptibility to Infectious Disease.” Nature Reviews Genetics 13 (3): 175–88.
37. Chi, Xinxin, Wei Jin, Xiaohong Zhao, Tian Xie, Jing Shao, Xue Bai, Yu Jiang, Xiaohu Wang, and Chen Dong. 2022. “RORγt Expression in Mature TH17 Cells Safeguards Their Lineage Specification by Inhibiting Conversion to TH2 Cells.” Science Advances 8 (34): eabn7774.
38. Chin, Kai Ling, Maria E Sarmiento, Nadine Alvarez-Cabrera, Mohd Nor Norazmi, and Armando Acosta. 2020. “Pulmonary Non-Tuberculous Mycobacterial Infections: Current State and Future Management.” European Journal of Clinical Microbiology & Infectious Diseases 39 (5): 799–826.
39. Chin, Voon K, Tze Y Lee, Basir Rusliza, and Pei P Chong. 2016. “Dissecting Candida Albicans Infection from the Perspective of C. Albicans Virulence and Omics Approaches on Host–Pathogen Interaction: A Review.” International Journal of Molecular Sciences 17 (10):1643.
40. Choi, Young Jin, Hwi Jun Kim, Hee Bong Shin, Hae Seon Nam, Sang Han Lee, Joon Soo Park, Kwi Sung Park, and Kyoung Ah Baek. 2012. “Evaluation of Peptide Nucleic Acid Probe-Based Real-Time PCR for Detection of Mycobacterium Tuberculosis Complex and Nontuberculous Mycobacteria in Respiratory Specimens.” Annals of Laboratory Medicine 32 (4): 257–63.
41. Chou, Janet, Craig D Platt, Saddiq Habiballah, Alan A Nguyen, Megan Elkins, Sabrina Weeks, Zachary Peters, et al. 2021. “Mechanisms Underlying Genetic Susceptibility to Multisystem Inflammatory Syndrome in Children (MIS-C).” Journal of Allergy and Clinical Immunology 148 (3): 732-738.e1.
42. Ciancanelli, Michael J, Sarah X L Huang, Priya Luthra, Hannah Garner, Yuval Itan, Stefano Volpi, Fabien G Lafaille, et al. 2015. “Life-Threatening Influenza and Impaired Interferon Amplification in Human IRF7 Deficiency.” Science 348 (6233): 448–53.
43. Clohisey, Sara, and John Kenneth Baillie. 2019. “Host Susceptibility to Severe Influenza A Virus Infection.” Critical Care 23 (1): 303.
44. Courtois, G, and A Smahi. 2006. “NF-ΚB-Related Genetic Diseases.” Cell Death & Differentiation 13 (5): 843–51.
45. Crow, Yanick J. 2011. “Type I Interferonopathies: A Novel Set of Inborn Errors of Immunity.” Annals of the New York Academy of Sciences 1238 (1): 91–98.
46. Crow, Yanick J, and Nicolas Manel. 2015. “Aicardi–Goutières Syndrome and the Type I Interferonopathies.” Nature Reviews Immunology 15 (7): 429–40.
47. Curtis, James, Yang Luo, Helen L Zenner, Delphine Cuchet-Lourenço, Changxin Wu, Kitty Lo, Mailis Maes, et al. 2015. “Susceptibility to Tuberculosis Is Associated with Variants in the ASAP1 Gene Encoding a Regulator of Dendritic Cell Migration.” Nature Genetics 47 (5): 523–27.
48. Darrason, Marie. 2013. “Unifying Diseases through Common Genetic Mechanisms: The Example of the Genetic Theory of Infectious Diseases.” Theoretical Medicine and Bioethics 34 (4): 327–44.
49. Decker, THOMAS, PAVEL Kovarik, and Andras Meinke. 1997. “GAS Elements: A Few Nucleotides with a Major Impact on Cytokine-Induced Gene Expression.” Journal of Interferon & Cytokine Research 17 (3): 121–34.
50. Depner, Mark, Sebastian Fuchs, Jan Raabe, Natalie Frede, Cristina Glocker, Rainer Doffinger, Effrossyni Gkrania-Klotsas, et al. 2016. “The Extended Clinical Phenotype of 26 Patients with Chronic Mucocutaneous Candidiasis Due to Gain-of-Function Mutations in STAT1.” Journal of Clinical Immunology 36 (1): 73–84.
51. Deyà-Martínez, Angela, Rivière, Jaques G, Pérsio Roxo-Junior, Ramakers, Jan, Bloomfield Marketa, Paloma Guisado Hernandez, Pilar Blanco Lobo, et al. 2022. “Impact of JAK Inhibitors in Pediatric Patients with STAT1 Gain of Function (GOF) Mutations—10 Children and Review of the Literature.” Journal of Clinical Immunology 42 (5): 1071–82.
52. Dietz, S M, D van Stijn, D Burgner, M Levin, I M Kuipers, B A Hutten, and T W Kuijpers. 2017. “Dissecting Kawasaki Disease: A State-of-the-Art Review.” European Journal of Pediatrics 176 (8): 995–1009.
53. Dolečková, Věra, J Viklický, L Šula, and Dagmar Kubecová. 1977. “Fatal Generalized BCG Histiocytosis.” Tubercle 58 (1): 13–18.
54. Dolezalova, Karolina and Gopfertova, Dana. 2021. “Ten Years’ Experience with the Discontinuation of the Bacillus Calmette–Guérin Vaccination in the Czech Republic.” International Journal of Mycobacteriology 10 (4): 193–98.
55. Dolezalova Karolina, Strachan Tomas, Matej Radoslav, Ricna Dita, Bloomfield, Marketa. 2022. “Manifestations of Cutaneous Mycobacterial Infections in Inborn Errors of IL-12, IL-23/IFNy Immunity.” European Journal of Dermatology. 2022; 7;32(4):1-10..
56. Domer, Judith E. 1989. “Candida Cell Wall Mannan: A Polysaccharide with Diverse Immunologic Properties.” Critical Reviews in Microbiology 17 (1): 33–51.
57. Dorman, Susan E, Capucine Picard, David Lammas, Klaus Heyne, Jaap T van Dissel, Richard Baretto, Sergio D Rosenzweig, et al. 2004. “Clinical Features of Dominant and Recessive Interferon γ Receptor 1 Deficiencies.” The Lancet 364 (9451): 2113–21.
58. Drummond, Rebecca A, Shinobu Saijo, Yoichiro Iwakura, and Gordon D Brown. 2011. “The Role of Syk/CARD9 Coupled C-Type Lectins in Antifungal Immunity.” European Journal of Immunology 41 (2): 276–81.
59. Duncan, Christopher J.A., and Sophie Hambleton. 2014. “Host Genetic Factors in Susceptibility to Mycobacterial Disease.” Clinical Medicine, Journal of the Royal College of Physicians of London 14 (6): S17–21.
60. Dupuis, Stéphanie, Catherine Dargemont, Claire Fieschi, Nicolas Thomassin, Sergio Rosenzweig, Jeff Harris, Steven M Holland, Robert D Schreiber, and Jean-Laurent Casanova. 2001. “Impairment of Mycobacterial But Not Viral Immunity by a Germline Human STAT1 Mutation.” Science 293 (5528): 300–303.
61. Durandy, Anne, Sven Kracker, and Alain Fischer. 2013. “Primary Antibody Deficiencies.” Nature Reviews Immunology 13 (7): 519–33.
62. Dvořáček C, Mores A, Neoral L. 1959. “BCG.” Rozhledy v Tuberkulose a v Nemocech Plicních., no. 19: 107–14.
63. Elsori, Deena H, Valentin P Yakubenko, Talat Roome, Praveena S Thiagarajan, Ashish Bhattacharjee, Satya P Yadav, and Martha K Cathcart. 2011. “Protein Kinase Cδ Is a Critical Component of Dectin-1 Signaling in Primary Human Monocytes.” Journal of Leukocyte Biology 90 (3): 599–611.
64. Eski, Aykut, Gökçen Kartal Öztürk, Figen Gülen, Candan Çiçek, and Esen Demir. 2019. “Risk Factors for Influenza Virus Related Severe Lower Respiratory Tract Infection in Children.” The Pediatric Infectious Disease Journal 38 (11).
65. Fang, Fang, Liang Zhao, Ming-jun Jiang, Yan Wang, and Qian-Qiu Wang. 2008. “Epidermodysplasia Verruciformis with Severe Hand and Foot Deformity Successfully Treated with Surgical Excision.” The International Journal of Surgical Reconstruction 61 (3): 338–41.
66. Feinberg, Jacqueline, Claire Fieschi, Rainer Doffinger, Max Feinberg, Tony Leclerc, Stéphanie Boisson-Dupuis, Capucine Picard, et al. 2004. “Bacillus Calmette Guérin Triggers the IL-12/IFN-γ Axis by an IRAK-4- and NEMO-Dependent, Non-Cognate Interaction between Monocytes, NK, and T Lymphocytes.” European Journal of Immunology 34 (11): 3276–84.
67. Ferguson, J S, and L S Schlesinger. 2000. “Pulmonary Surfactant in Innate Immunity and the Pathogenesis of Tuberculosis.” Tubercle and Lung Disease 80 (4): 173–84.
68. Figueroa, J E, and P Densen. 1991. “Infectious Diseases Associated with Complement Deficiencies.” Clinical Microbiology Reviews 4 (3): 359–95.
69. Forbes, Lisa R., Tiphanie P. Vogel, Megan A. Cooper, Johana Castro-Wagner, Edith Schussler, Katja G. Weinacht, Ashley S. Plant, et al. 2018. “Jakinibs for the Treatment of Immune Dysregulation in Patients with Gain-of-Function Signal Transducer and Activator of Transcription 1 (STAT1) or STAT3 Mutations.” Journal of Allergy and Clinical Immunology 142 (5).
70. Fraga, Alexandra G, Ana Margarida Barbosa, Catarina M Ferreira, João Fevereiro, Jorge Pedrosa, and Egídio Torrado. 2018. “Immune-Evasion Strategies of Mycobacteria and Their Implications for the Protective Immune Response.” Current Issues in Molecular Biology (7) .
71. Frey-Jakobs, Stefanie, Julia M Hartberger, Manfred Fliegauf, Claudia Bossen, Magdalena L Wehmeyer, Johanna C Neubauer, Alla Bulashevska, et al. 2018. “ZNF341 Controls STAT3 Expression and Thereby Immunocompetence.” Science Immunology 3 (24): eaat4941.
72. Gazendam, Roel P, John L van Hamme, Anton T J Tool, Michel van Houdt, Paul J J H Verkuijlen, Martin Herbst, Johannes G Liese, et al. 2014. “Two Independent Killing Mechanisms of Candida Albicans by Human Neutrophils: Evidence from Innate Immunity Defects.” Blood 124 (4): 590–97.
73. Gianella-Borradori, Athos, Luca Borradori, and Peter Späth. 1988. “C5 Deficiency and Meningitis in a Swiss Family.” Archives of Internal Medicine 148 (3): 754.
74. Giovannozzi, Simone, Jonas Demeulemeester, Rik Schrijvers, and Rik Gijsbers. 2021. “Transcriptional Profiling of STAT1 Gain-of-Function Reveals Common and Mutation-Specific Fingerprints.” Frontiers in Immunology 12 (February): 1–14.
75. Glaser, Carol A, Kathleen Winter, Kara DuBray, Kathleen Harriman, Timothy M Uyeki, James Sejvar, Sabrina Gilliam, and Janice K Louie. 2012. “A Population-Based Study of Neurologic Manifestations of Severe Influenza A(H1N1)Pdm09 in California.” Clinical Infectious Diseases 55 (4): 514–20.
76. Glöckner, Andreas, Angela Steinbach, Jörg Janne Vehreschild, and Oliver A Cornely. 2009. “Treatment of Invasive Candidiasis with Echinocandins.” Mycoses 52 (6): 476–86.
77. Gow, Neil A R, Frank L van de Veerdonk, Alistair J P Brown, and Mihai G Netea. 2012. “Candida Albicans Morphogenesis and Host Defence: Discriminating Invasion from Colonization.” Nature Reviews Microbiology 10 (2): 112–22.
78. Griffith, Jason W, Caroline L Sokol, and Andrew D Luster. 2014. “Chemokines and Chemokine Receptors: Positioning Cells for Host Defense and Immunity.” Annual Review of Immunology 32 (1): 659–702.
79. Guérin, Antoine, Gaspard Kerner, Nico Marr, Janet G Markle, Florence Fenollar, Natalie Wong, Sabri Boughorbel, et al. 2018. “IRF4 Haploinsufficiency in a Family with Whipple’s Disease.” Edited by Jos W M van der Meer. ELife 7 (March): e32340.
80. Hadders, Michael A., Doryen Bubeck, Pietro Roversi, Svetlana Hakobyan, Federico Forneris, B. Paul Morgan, Michael K. Pangburn, Oscar Llorca, Susan M. Lea, and Piet Gros. 2012. “Assembly and Regulation of the Membrane Attack Complex Based on Structures of C5b6 and SC5b9.” Cell Reports 1 (3): 200–207.
81. Henkle, Emily, and Kevin L Winthrop. 2015. “Nontuberculous Mycobacteria Infections in Immunosuppressed Hosts.” Clinics in Chest Medicine 36 (1): 91–99.
82. Hermansen, Thomas Stig, Vibeke Østergaard Thomsen, Troels Lillebaek, and Pernille Ravn. 2014. “Non-Tuberculous Mycobacteria and the Performance of Interferon Gamma Release Assays in Denmark.” PLOS ONE 9 (4): e93986.
83. Hernandez, Nicholas, Isabelle Melki, Huie Jing, Tanwir Habib, Susie S Y Huang, Jeffrey Danielson, Tomasz Kula, et al. 2018. “Life-Threatening Influenza Pneumonitis in a Child with Inherited IRF9 Deficiency.” Journal of Experimental Medicine 215 (10): 2567–85.
84. Hershkovitz, Israel, Helen D Donoghue, David E Minnikin, Gurdyal S Besra, Oona Y-C. Lee, Angela M Gernaey, Ehud Galili, et al. 2008. “Detection and Molecular Characterization of 9000-Year-Old Mycobacterium Tuberculosis from a Neolithic Settlement in the Eastern Mediterranean.” PLOS ONE 3 (10): e3426.
85. Hiller, Julia, Beate Hagl, Renate Effner, Anne Puel, Martin Schaller, Birgit Mascher, Stefanie Eyerich, et al. 2018. “STAT1 Gain-of-Function and Dominant Negative STAT3 Mutations Impair IL-17 and IL-22 Immunity Associated with CMC.” Journal of Investigative Dermatology 138 (3): 711–14.
86. Horvath, Curt M. 2000. “STAT Proteins and Transcriptional Responses to Extracellular Signals.” Trends in Biochemical Sciences 25 (10): 496–502.
87. Jain, Ajay, Sabina Kaczanowska, and Eduardo Davila. 2014. “IL-1 Receptor-Associated Kinase Signaling and Its Role in Inflammation, Cancer Progression, and Therapy Resistance.” Frontiers in Immunology 5 (NOV): 1–8.
88. Jalaledin, Ghanavi, Farnia Poopak, Farnia Parissa, and Velayati Ali Akbar. 2021. “The Role of Interferon-Gamma and Interferon-Gamma Receptor in Tuberculosis and Nontuberculous Mycobacterial Infections.” International Journal of Mycobacteriology 10 (4): 349–57.
89. Jones, Makoto M, Kevin L Winthrop, Scott D Nelson, Scott L Duvall, Olga V Patterson, Kevin E Nechodom, Kimberly E Findley, Lewis J Radonovich Jr., Matthew H Samore, and Kevin P Fennelly. 2018. “Epidemiology of Nontuberculous Mycobacterial Infections in the U.S. Veterans Health Administration.” PLOS ONE 13 (6): e0197976.
90. Jong, Sarah J. de, Elias Imahorn, Peter Itin, Jouni Uitto, Gérard Orth, Emmanuelle Jouanguy, Jean Laurent Casanova, and Bettina Burger. 2018. “Epidermodysplasia Verruciformis: Inborn Errors of Immunity to Human Beta-Papillomaviruses.” Frontiers in Microbiology 9 (JUN).
91. Jouanguy, Emmanuelle, Frédéric Altare, Salma Lamhamedi, Patrick Revy, Jean-François Emile, Melanie Newport, Michael Levin, et al. 1996. “Interferon-γ –Receptor Deficiency in an Infant with Fatal Bacille Calmette–Guérin Infection.” New England Journal of Medicine 335 (26): 1956–62.
92. Jouanguy, Emmanuelle, Salma Lamhamedi-Cherradi, David Lammas, Susan E Dorman, Marie-Claude Fondanèche, Stéphanie Dupuis, Rainer Döffinger, et al. 1999. “A Human IFNGR1 Small Deletion Hotspot Associated with Dominant Susceptibility to Mycobacterial Infection.” Nature Genetics 21 (4):
93. Kampmann, Beate, Cheryl Hemingway, Alick Stephens, Robert Davidson, Anna Goodsall, Suzanne Anderson, Mark Nicol, et al. 2005. “Acquired Predisposition to Mycobacterial Disease Due to Autoantibodies to IFN-γ.” The Journal of Clinical Investigation 115 (9): 2480–88.
94. Kappelman, John, Mehmet Cihat Alçiçek, Nizamettin Kazancı, Michael Schultz, Mehmet Özkul, and Şevket Şen. 2008. “First Homo Erectus from Turkey and Implications for Migrations into Temperate Eurasia.” American Journal of Physical Anthropology 135 (1): 110–16.
95. Kerner, Gaspard, Jérémie Rosain, Antoine Guérin, Ahmad Al-Khabaz, Carmen Oleaga-Quintas, Franck Rapaport, Michel J Massaad, et al. 2020. “Inherited Human IFN-γ Deficiency Underlies Mycobacterial Disease.” The Journal of Clinical Investigation 130 (6): 3158–71.
96. Khan, Taj Ali, Kalsoom Kalsoom, Asif Iqbal, Huma Asif, Hazir Rahman, Syed Omar Farooq, Hassan Naveed, et al. 2016. “A Novel Missense Mutation in the NADPH Binding Domain of CYBB Abolishes the NADPH Oxidase Activity in a Male Patient with Increased Susceptibility to Infections.” Microbial Pathogenesis 100: 163–69.
97. Khandelwal, Shreya, and Widhi Dubey. 2020. “Overview of Mycobacterium: A Review.” European Journal of Molecular & Clinical Medicine 7 (11): 6198–6213.
98. Kiykim, Ayca, Louis Marie Charbonnier, Arzu Akcay, Elif Karakoc-Aydiner, Ahmet Ozen, Gulyuz Ozturk, Talal A Chatila, and Safa Baris. 2019. “Hematopoietic Stem Cell Transplantation in Patients with Heterozygous STAT1 Gain-of-Function Mutation.” Journal of Clinical Immunology 39 (1): 37–44.
99. Koch, Anastasia, and Valerie Mizrahi. 2018. “<em>Mycobacterium Tuberculosis</Em>.” Trends in Microbiology 26 (6): 555–56.
100. Kojima, Takeshi, Takahiko Horiuchi, H Nishizaka, Yasuo Fukumori, Tetsuki Amano, Kohei Nagasawa, Yoshiyuki Niho, and Kenshi Hayashi. 1998. “Genetic Basis of Human Complement C8 Alpha-Gamma Deficiency.” Journal of Immunology (Baltimore, Md. : 1950) 161 (7): 3762–66.
101. Krismer, Bernhard, Christopher Weidenmaier, Alexander Zipperer, and Andreas Peschel. 2017. “The Commensal Lifestyle of Staphylococcus Aureus and Its Interactions with the Nasal Microbiota.” Nature Reviews Microbiology 15 (11): 675–87.
102. Ku, Chen Lung, Chih Yu Chi, Horst von Bernuth, and Rainer Doffinger. 2020. “Autoantibodies against Cytokines: Phenocopies of Primary Immunodeficiencies?” Human Genetics 139 (6–7): 783–94.
103. Ku, Cheng-Lung, Horst von Bernuth, Capucine Picard, Shen-Ying Zhang, Huey-Hsuan Chang, Kun Yang, Maya Chrabieh, et al. 2007. “Selective Predisposition to Bacterial Infections in IRAK-4–Deficient Children: IRAK-4–Dependent TLRs Are Otherwise Redundant in Protective Immunity .” Journal of Experimental Medicine 204 (10): 2407–22.
104. Ku, Cheng-Lung, Capucine Picard, Melinda Erdös, Axel Jeurissen, Jacinta Bustamante, Anne Puel, Horst von Bernuth, et al. 2007. “IRAK4 and NEMO Mutations in Otherwise Healthy Children with Recurrent Invasive Pneumococcal Disease.” Journal of Medical Genetics 44 (1): 16–23.
105. Lamb, Ruth C, and Goutam Dawn. 2014. “Cutaneous Non-Tuberculous Mycobacterial Infections.” International Journal of Dermatology 53 (10): 1197–1204.
106. Lammas, D A, E De Heer, J D Edgar, V Novelli, A Ben-Smith, R Baretto, P Drysdale, et al. 2002. “Heterogeneity in the Granulomatous Response to Mycobacterial Infection in Patients with Defined Genetic Mutations in the Interleukin 12-Dependent Interferon-Gamma Production Pathway.” International Journal of Experimental Pathology 83 (1): 1–20.
107. Lee, Pui Y, Craig D Platt, Sabrina Weeks, Rachael F Grace, George Maher, Kasey Gauthier, Sridevi Devana, et al. 2020. “Immune Dysregulation and Multisystem Inflammatory Syndrome in Children (MIS-C) in Individuals with Haploinsufficiency of SOCS1. Journal of Allergy and Clinical Immunology 146 (5): 1194-1200.e1.
108. Lee, Wen-I., Jing-Long Huang, Ting-Shu Wu, Ming-Hsun Lee, I.-Jung Chen, Kuang-Hiu Yu, Chien-Ying Liu, et al. 2013. “Patients with Inhibitory and Neutralizing Auto-Antibodies to Interferon-γ Resemble the Sporadic Adult-Onset Phenotype of Mendelian Susceptibility to Mycobacterial Disease (MSMD) Lacking Bacille Calmette–Guerin (BCG)-Induced Diseases.” Immunobiology 218 (5): 762–71.
109. Leiding, Jennifer W, Satoshi Okada, David Hagin, Mario Abinun, Anna Shcherbina, Dmitry N Balashov, Vy H D Kim, et al. 2017. “Hematopoietic Stem Cell Transplantation in Patients with Gain-of-Function Signal Transducer and Activator of Transcription 1 Mutations.” Journal of Allergy and Clinical Immunology.
110. Lewandowsky, F, and W Lutz. 1922. “Ein Fall Einer Bisher Nicht Beschriebenen Hauterkrankung (Epidermodysplasia Verruciformis).” Archiv Für Dermatologie Und Syphilis 141 (2): 193–203.
111. Lewis, Lisa A, and Sanjay Ram. 2014. “Meningococcal Disease and the Complement System.” Virulence 5 (1): 98–126.
112. Li, Danyang, and Minghua Wu. 2021. “Pattern Recognition Receptors in Health and Diseases.” Signal Transduction and Targeted Therapy 6 (1): 291..
113. Li, Yong, Yujiong Wang, and Xiaoming Liu. 2012. “The Role of Airway Epithelial Cells in Response to Mycobacteria Infection.” Edited by S Sozzani. Clinical and Developmental Immunology 2012: 791392.
114. Lim, Hye Kyung, Sarah X L Huang, Jie Chen, Gaspard Kerner, Olivier Gilliaux, Paul Bastard, Kerry Dobbs, et al. 2019. “Severe Influenza Pneumonitis in Children with Inherited TLR3 Deficiency.” Journal of Experimental Medicine 216 (9): 2038–56.
115. Lindesmith, Lisa, Christine Moe, Severine Marionneau, Nathalie Ruvoen, Xi Jiang, Lauren Lindblad, Paul Stewart, Jacques LePendu, and Ralph Baric. 2003. “Human Susceptibility and Resistance to Norwalk Virus Infection.” Nature Medicine 9 (5): 548–53.
116. Liu, Luyan, Satoshi Okada, Xiao-Fei Kong, Alexandra Y Kreins, Sophie Cypowyj, Avinash Abhyankar, Julie Toubiana, et al. 2011. “Gain-of-Function Human STAT1 Mutations Impair IL-17 Immunity and Underlie Chronic Mucocutaneous Candidiasis.” The Journal of Experimental Medicine 208 (8): 1635–48.
117. Liu, Rong, William A. Paxton, Sunny Choe, Daniel Ceradini, Scott R. Martin, Richard Horuk, Marcy E. MacDonald, Heidi Stuhlmann, Richard A. Koup, and Nathaniel R. Landau. 1996. “Homozygous Defect in HIV-1 Coreceptor Accounts for Resistance of Some Multiply-Exposed Individuals to HIV-1 Infection.” Cell 86 (3): 367–77.
118. Liu, Wei, and Dong Lai Ma. 2020. “Severe Epidermodysplasia Verruciformis.” Mayo Clinic Proceedings 95 (9): 2035.
119. Liu, Zhenxing, Mi Zhou, Chao Yuan, Zhengyi Ni, Wenqiang Liu, Yang Tan, Dazhi Zhang, et al. 2022. “Two Novel STAT1 Mutations Cause Mendelian Susceptibility to Mycobacterial Disease.” Biochemical and Biophysical Research Communications 591: 124–29.
120. Lockhart, Shawn R, Kizee A Etienne, Snigdha Vallabhaneni, Joveria Farooqi, Anuradha Chowdhary, Nelesh P Govender, Arnaldo Lopes Colombo, et al. 2017. “Simultaneous Emergence of Multidrug-Resistant Candida Auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses.” Clinical Infectious Diseases 64 (2): 134–40.
121. López-Martínez, Rubén. 2010. “Candidosis, a New Challenge.” Clinics in Dermatology 28 (2): 178–84.
122. López-Varela, Elisa, Alberto L García-Basteiro, Begoña Santiago, Dirk Wagner, Jakko van Ingen, and Beate Kampmann. 2015. “Non-Tuberculous Mycobacteria in Children: Muddying the Waters of Tuberculosis Diagnosis.” The Lancet Respiratory Medicine 3 (3): 244–56.
123. Ma, Cindy S, Gary Y J Chew, Nicholas Simpson, Archana Priyadarshi, Melanie Wong, Bodo Grimbacher, David A Fulcher, Stuart G Tangye, and Matthew C Cook. 2008. “Deficiency of Th17 Cells in Hyper IgE Syndrome Due to Mutations in STAT3 .” Journal of Experimental Medicine 205 (7): 1551–57.
124. McCullers, Jonathan A. 2014. “The Co-Pathogenesis of Influenza Viruses with Bacteria in the Lung.” Nature Reviews Microbiology 12 (4): 252–62.
125. Medzhitov, Ruslan, and Charles Janeway. 2000. “Innate Immunity.” New England Journal of Medicine 343 (5): 338–44.
126. Millsop, Jillian W, and Nasim Fazel. 2016. “Oral Candidiasis.” Clinics in Dermatology 34 (4): 487–94.
127. Mizoguchi, Yoko, and Satoshi Okada. 2021. “Inborn Errors of STAT1 Immunity.” Current Opinion in Immunology 72: 59–64.
128. Mogensen, Trine H. 2009. “Pathogen Recognition and Inflammatory Signaling in Innate Immune Defenses.” Clinical Microbiology Reviews 22 (2): 240–73.
129. Muderris, T, S Kaya, B Ormen, A Aksoy Gokmen, C Varer Akpinar, and S Yurtsever Gul. 2020. “Mortality and Risk Factor Analysis for Candida Blood Stream Infection: A Three-Year Retrospective Study.” Journal de Mycologie Médicale 30 (3): 101008.
130. Nam, Sorim, and Jong-Seok Lim. 2016. “Essential Role of Interferon Regulatory Factor 4 (IRF4) in Immune Cell Development.” Archives of Pharmacal Research 39 (11): 1548–55.
131. Nanki, Toshihiro, Ikumi Onoue, Kenji Nagasaka, Aiko Takayasu, Masashi Ebisawa, Tadashi Hosoya, Toshizumi Shirai, et al. 2013. “Suppression of Elevations in Serum C Reactive Protein Levels by Anti-IL-6 Autoantibodies in Two Patients with Severe Bacterial Infections.” Annals of the Rheumatic Diseases.
132. Netea, Mihai G, Leo A B Joosten, Jos W M van der Meer, Bart-Jan Kullberg, and Frank L van de Veerdonk. 2015. “Immune Defence against Candida Fungal Infections.” Nature Reviews Immunology 15 (10): 630–42.
133. Nguyen, Mai T T, Jan Pødenphant, and Pernille Ravn. 2013. “Three Cases of Severely Disseminated Staphylococcus Aureus Infection in Patients Treated with Tocilizumab.” Case Reports 2013.
134. Nicolas, Radomski, Cambau Emmanuelle, Moulin Laurent, Haenn Sophie, Moilleron Régis, and Lucas Françoise S. 2010. “Comparison of Culture Methods for Isolation of Nontuberculous Mycobacteria from Surface Waters.” Applied and Environmental Microbiology 76 (11): 3514–20.
135. Nicolle, C. 1937. Destin Des Maladies Infectieuses. Alcan, Paris.
136. Noma, Kosuke, Yoko Mizoguchi, Miyuki Tsumura, and Satoshi Okada. 2022. “Mendelian Susceptibility to Mycobacterial Diseases: State of the Art.” Clinical Microbiology and Infection S1198-743X(22)00143-4.
137. Notarangelo, Luigi, Jean Laurent Casanova, Mary Ellen Conley, Helen Chapel, Alain Fischer, Jennifer Puck, Chaim Roifman, Reinhard Seger, and Raif S. Geha. 2006. “Primary Immunodeficiency Diseases: An Update from the International Union of Immunological Societies Primary Immunodeficiency Diseases Classification Committee Meeting in Budapest, 2005.” The Journal of Allergy and Clinical Immunology 117 (4): 883–96.
138. Nürnberger, W, H Pietsch, R Seger, T Bufon, and V Wahn. 1989. “Familial Deficiency of the Seventh Component of Complement Associated with Recurrent Meningococcal Infections.” European Journal of Pediatrics 148 (8): 758–60.
139. Ochs, Hans D, and Walter H Hitzig. 2012. “History of Primary Immunodeficiency Diseases.” Current Opinion in Allergy and Clinical Immunology 12 (6).
140. Okada, S., J. G. Markle, E. K. Deenick, F. Mele, D. Averbuch, M. Lagos, M. Alzahrani, et al. 2015. “Impairment of Immunity to Candida and Mycobacterium in Humans with Bi-Allelic RORC Mutations.” Science 349 (6248): 606–13.
141. Okada, Satoshi, Takaki Asano, Kunihiko Moriya, Stephanie Boisson-Dupuis, Masao Kobayashi, Jean Laurent Casanova, and Anne Puel. 2020. “Human STAT1 Gain-of-Function Heterozygous Mutations: Chronic Mucocutaneous Candidiasis and Type I Interferonopathy.” Journal of Clinical Immunology 40 (8): 1065–81.
142. Olbrich, Peter, Maria Teresa Martínez-Saavedra, José Maria Perez-Hurtado, Cristina Sanchez, Berta Sanchez, Caroline Deswarte, Ignacio Obando, et al. 2015. “Diagnostic and Therapeutic Challenges in a Child with Complete Interferon-γ Receptor 1 Deficiency.” Pediatric Blood & Cancer 62 (11): 2036–39.
143. Osamu Hirata, Satoshi Okada, Miyuki Tsumura, Reiko Kagawa, Mizuka Miki, Hiroshi Kawaguchi, Kazuhiro Nakamura, et al. 2013. “Heterozygosity for the Y701C STAT1 Mutation in a Multiplex Kindred with Multifocal Osteomyelitis.” Haematologica 98 (10 SE-Articles): 1641–49.
144. Ovadia, Adi, Nigel Sharfe, Cynthia Hawkins, Suzanne Laughlin, and Chaim M Roifman. 2018. “Two Different STAT1 Gain-of-Function Mutations Lead to Diverse IFN-γ-Mediated Gene Expression.” Npj Genomic Medicine 3 (1): 23.
145. Park, Bonggoo, and George Y Liu. 2020. “Staphylococcus Aureus and Hyper-IgE Syndrome.” International Journal of Molecular Sciences 21 (23).
146. Pestka, Sidney, Christopher D Krause, and Mark R Walter. 2004. “Interferons, Interferon-like Cytokines, and Their Receptors.” Immunological Reviews 202 (1): 8–32.
147. Picard, Capucine, Jean-Laurent Casanova, and Laurent Abel. 2006. “Mendelian Traits That Confer Predisposition or Resistance to Specific Infections in Humans.” Current Opinion in Immunology 18 (4): 383–90.
148. Picard, Capucine, Jean-Laurent Casanova, and Anne Puel. 2011. “Infectious Diseases in Patients with IRAK-4, MyD88, NEMO, or IκBα Deficiency.” Clinical Microbiology Reviews 24 (3): 490–97.
149. Picard, Capucine, Anne Puel, Marion Bonnet, Cheng-Lung Ku, Jacinta Bustamante, Kun Yang, Claire Soudais, et al. 2003. “Pyogenic Bacterial Infections in Humans with IRAK-4 Deficiency.” Science 299 (5615): 2076–79.
150. Piskorska, Katarzyna, Magdalena Sikora, Marlena Gołaś, Maria Da̧bkowska, Leszek Pa̧czek, and Ewa Swoboda-Kopeć. 2014. “Invasive Candidiasis Serological Diagnosis in Solid Organ Transplant Recipients.” Central European Journal of Immunology 39 (2): 187–92.
151. Plantinga, Theo S, Melissa D Johnson, William K Scott, Leo A B Joosten, Jos W M van der Meer, John R Perfect, Bart Jan Kullberg, and Mihai G Netea. 2012. “Human Genetic Susceptibility to Candida Infections.” Medical Mycology 50 (8): 785–94.
152. Porvaznik, I, I Solovič, and J Mokrý. 2017. “Non-Tuberculous Mycobacteria: Classification, Diagnostics, and Therapy BT - Respiratory Treatment and Prevention.” Cham: Springer International Publishing 19–25.
153. Puel, Anne. 2020. “Human Inborn Errors of Immunity Underlying Superficial or Invasive Candidiasis.” Human Genetics 139 (6): 1011–22.
154. Puel, Anne, Sophie Cypowyj, Jacinta Bustamante, Jill F. Wright, Luyan Liu, Hye Kyung Lim, Mélanie Migaud, et al. 2011a. “Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity.” Science 332 (6025): 65–68.
155. Puel, Anne, Sophie Cypowyj, Jacinta Bustamante, Jill F Wright, Luyan Liu, Hye Kyung Lim, Mélanie Migaud, et al. 2011b. “Chronic Mucocutaneous Candidiasis in Humans with Inborn Errors of Interleukin-17 Immunity.” Science 332 (6025): 65–68.
156. Puel, Anne, Rainer Döffinger, Angels Natividad, Maya Chrabieh, Gabriela Barcenas-Morales, Capucine Picard, Aurélie Cobat, et al. 2010. “Autoantibodies against IL-17A, IL-17F, and IL-22 in Patients with Chronic Mucocutaneous Candidiasis and Autoimmune Polyendocrine Syndrome Type I.” Journal of Experimental Medicine 207 (2): 291–97.
157. Puel, Anne, Capucine Picard, Mathie Lorrot, Charlotte Pons, Maya Chrabieh, Lazaro Lorenzo, Maria Mamani-Matsuda, Emmanuelle Jouanguy, Dominique Gendrel, and Jean-Laurent Casanova. 2008. “Recurrent Staphylococcal Cellulitis and Subcutaneous Abscesses in a Child with Autoantibodies against IL-6.” The Journal of Immunology.
158. Ramoz, Nicolas, Luis-Alfredo Rueda, Bakar Bouadjar, Luz-Stella Montoya, Gérard Orth, and Michel Favre. 2002. “Mutations in Two Adjacent Novel Genes Are Associated with Epidermodysplasia Verruciformis.” Nature Genetics 32 (4): 579–81.
159. Raoult, Didier, Marie L Birg, Bernard La Scola, Pierre E Fournier, Maryse Enea, Hubert Lepidi, Veronique Roux, et al. 2000. “Cultivation of the Bacillus of Whipple’s Disease.” New England Journal of Medicine 342 (9): 620–25.
160. Reichenbach, Janine, Sergio Rosenzweig, Rainer Döffinger, Stéphanie Dupuis, Steven M Holland, and Jean-Laurent Casanova. 2001. “Mycobacterial Diseases in Primary Immunodeficiencies.” Current Opinion in Allergy and Clinical Immunology 1 (6).
161. Riphagen, Shelley, Xabier Gomez, Carmen Gonzalez-Martinez, Nick Wilkinson, and Paraskevi Theocharis. 2020. “Hyperinflammatory Shock in Children during COVID-19 Pandemic.” The Lancet 395 (10237): 1607–8.
162. Romberg, Neil, Henner Morbach, Monica G Lawrence, Sanghyun Kim, Insoo Kang, Steven M Holland, Joshua D Milner, and Eric Meffre. 2017. “Gain-of-Function <em>STAT1</Em> Mutations Are Associated with PD-L1 Overexpression and a Defect in B-Cell Survival.” Journal of Allergy and Clinical Immunology 131 (6): 1691–93.
163. Rottman, Martin, Claire Soudais, Guillaume Vogt, Laurent Renia, Jean-François Emile, Hélène Decaluwe, Jean-Louis Gaillard, and Jean-Laurent Casanova. 2008. “IFN-γ Mediates the Rejection of Haematopoietic Stem Cells in IFN-ΓR1-Deficient Hosts.” PLOS Medicine 5 (1): e26.
164. Russell, David G. 2007. “Who Puts the Tubercle in Tuberculosis?” Nature Reviews Microbiology 5 (1): 39–47.
165. Saffert, Ryan T, and Robert F Kalejta. 2006. “Inactivating a Cellular Intrinsic Immune Defense Mediated by Daxx Is the Mechanism through Which the Human Cytomegalovirus Pp71 Protein Stimulates Viral Immediate-Early Gene Expression.” Journal of Virology 80 (8): 3863–71.
166. Sancho-shimizu, Vanessa, and Petter Brodin. 2021. “SARS-CoV-2 – Related MIS-C : A Key to the Viral and Genetic Causes of Kawasaki Disease ?” 218 (6).
167. Schelenz, Silke. 2008. “Management of Candidiasis in the Intensive Care Unit.” Journal of Antimicrobial Chemotherapy 61 (suppl_1): i31–34.
168. Schindler, Christian, David E Levy, and Thomas Decker. 2007. “JAK-STAT Signaling: From Interferons to Cytokines*.” Journal of Biological Chemistry 282 (28): 20059–63.
169. Shah, Kabeer K, Bobbi S Pritt, and Mariam P Alexander. 2017. “Histopathologic Review of Granulomatous Inflammation.” Journal of Clinical Tuberculosis and Other Mycobacterial Diseases 7: 1–12.
170. Shawn, Lockhart, Iqbal Naureen, Cleveland Angela A., Farley Monica M., Harrison Lee H., Bolden Carol B., Baughman Wendy, et al. 2012. “Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011.” Journal of Clinical Microbiology 50 (11): 3435–42.
171. Sheehy, Ann M, Nathan C Gaddis, Jonathan D Choi, and Michael H Malim. 2002. “Isolation of a Human Gene That Inhibits HIV-1 Infection and Is Suppressed by the Viral Vif Protein.” Nature 418 (6898): 646–50.
172. Sologuren, Ithaisa, María Teresa Martínez-Saavedra, Jordi Solé-Violán, Edgar de Borges de Oliveira Jr, Eva Betancor, Inmaculada Casas, Carmen Oleaga-Quintas, et al. 2018. “Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency.” Journal of Clinical Immunology 38 (4): 513–26.
173. Spencer, Sarah, Sevgi Köstel Bal, William Egner, Hana Lango Allen, Syed I Raza, Chi A Ma, Meltem Gürel, et al. 2019. “Loss of the Interleukin-6 Receptor Causes Immunodeficiency, Atopy, and Abnormal Inflammatory Responses.” The Journal of Experimental Medicine 216 (9): 1986 LP – 1998.
174. Stremlau, Matthew, Christopher M Owens, Michel J Perron, Michael Kiessling, Patrick Autissier, and Joseph Sodroski. 2004. “The Cytoplasmic Body Component TRIM5α Restricts HIV-1 Infection in Old World Monkeys.” Nature 427 (6977): 848–53.
175. Sveinbjornsson, Gardar, Daniel F Gudbjartsson, Bjarni V Halldorsson, Karl G Kristinsson, Magnus Gottfredsson, Jeffrey C Barrett, Larus J Gudmundsson, et al. 2016. “HLA Class II Sequence Variants Influence Tuberculosis Risk in Populations of European Ancestry.” Nature Genetics 48 (3): 318–22.
176. Swenson, Colin, Christa S. Zerbe, and Kevin Fennelly. 2018. “Host Variability in NTM Disease: Implications for Research Needs.” Frontiers in Microbiology 9.
177. Tanaka, Toshio, Masashi Narazaki, and Tadamitsu Kishimoto. 2011. “Anti-Interleukin-6 Receptor Antibody, Tocilizumab, for the Treatment of Autoimmune Diseases.” FEBS Letters 585 (23): 3699–3709.
178. Tanaka, Toshio, Masashi Narazaki, and Tadamitsu Kishimoto. 2014. “Il-6 in Inflammation, Immunity, And Disease.” Cold Spring Harbor Perspectives in Biology.
179. Tangye, Stuart G, Waleed Al-Herz, Aziz Bousfiha, Charlotte Cunningham-Rundles, Jose Luis Franco, Steven M Holland, Christoph Klein, et al. 2022. “Human Inborn Errors of Immunity: 2022 Update on the Classification from the International Union of Immunological Societies Expert Committee.” Journal of Clinical Immunology 24;1-3.
180. Taur, Prasad D., Vijaya Gowri, Ambreen Abdulwahab Pandrowala, Vaishnavi V. Iyengar, Akshaya Chougule, Zainab Golwala, Shraddha Chandak, et al. 2021. “Clinical and Molecular Findings in Mendelian Susceptibility to Mycobacterial Diseases: Experience From India.” Frontiers in Immunology 12 (February): 1–12.
181. Thomas-Rüddel, Daniel O, Peter Schlattmann, Mathias Pletz, Oliver Kurzai, and Frank Bloos. 2022. “Risk Factors for Invasive <em>Candida</Em> Infection in Critically Ill Patients: A Systematic Review and Meta-Analysis.” CHEST 161 (2): 345–55.
182. Thorven, Maria, Ammi Grahn, Kjell-Olof Hedlund, Hugo Johansson, Christer Wahlfrid, Göran Larson, and Lennart Svensson. 2005. “A Homozygous Nonsense Mutation (428G\&\#x2192;A) in the Human Secretor (FUT2) Gene Provides Resistance to Symptomatic Norovirus (GGII) Infections.” Journal of Virology 79 (24): 15351–55.
183. Thye, Thorsten, Ellis Owusu-Dabo, Fredrik O Vannberg, Reinout van Crevel, James Curtis, Edhyana Sahiratmadja, Yanina Balabanova, et al. 2012. “Common Variants at 11p13 Are Associated with Susceptibility to Tuberculosis.” Nature Genetics 44 (3): 257–59.
184. Thye, Thorsten, Fredrik O Vannberg, Sunny H Wong, Ellis Owusu-Dabo, Ivy Osei, John Gyapong, Giorgio Sirugo, et al. 2010. “Genome-Wide Association Analyses Identifies a Susceptibility Locus for Tuberculosis on Chromosome 18q11.2.” Nature Genetics 42 (9): 739–41.
185. Toubiana, Julie, Satoshi Okada, Julia Hiller, Matias Oleastro, Macarena Lagos Gomez, Juan Carlos Aldave Becerra, Marie Ouachée-Chardin, et al. 2016. “Heterozygous STAT1 Gain-of-Function Mutations Underlie an Unexpectedly Broad Clinical Phenotype.” Blood 127 (25): 3154–64.
186. Tournamille, Christophe, Yves Colin, Jean Pierre Cartron, and Caroline Le Van Kim. 1995. “Disruption of a GATA Motif in the Duffy Gene Promoter Abolishes Erythroid Gene Expression in Duffy–Negative Individuals.” Nature Genetics 10 (2): 224–28.
187. Tsumura, Miyuki, Mizuka Miki, Yoko Mizoguchi, Osamu Hirata, Shiho Nishimura, Moe Tamaura, Reiko Kagawa, Seiichi Hayakawa, Masao Kobayashi, and Satoshi Okada. 2022. “Enhanced Osteoclastogenesis in Patients with MSMD Due to Impaired Response to IFN-&#x3b3;” Journal of Allergy and Clinical Immunology 149 (1): 252-261.e6.
188. Tsumura, Miyuki, Satoshi Okada, Hidemasa Sakai, Shin’ichiro Yasunaga, Motoaki Ohtsubo, Takuji Murata, Hideto Obata, et al. 2012. “Dominant-Negative STAT1 SH2 Domain Mutations in Unrelated Patients with Mendelian Susceptibility to Mycobacterial Disease.” Human Mutation 33 (9): 1377–87.
189. Uzel, Gulbu, Elizabeth P. Sampaio, Monica G. Lawrence, Amy P. Hsu, Mary Hackett, Morna J. Dorsey, Richard J. Noel, et al. 2013. “Dominant Gain-of-Function STAT1 Mutations in FOXP3 Wild-Type Immune Dysregulation-Polyendocrinopathy-Enteropathy-X-Linked-like Syndrome.” Journal of Allergy and Clinical Immunology 131 (6).
190. Veerdonk, Frank L van de, Theo S Plantinga, Alexander Hoischen, Sanne P Smeekens, Leo A B Joosten, Christian Gilissen, Peer Arts, et al. 2011. “STAT1 Mutations in Autosomal Dominant Chronic Mucocutaneous Candidiasis.” New England Journal of Medicine 365 (1): 54–61.
191. Vinh, Donald C. 2011. “Insights into Human Antifungal Immunity from Primary Immunodeficiencies.” The Lancet Infectious Diseases 11 (10): 780–92.
192. Wang, Xiaowen, and Frank L van de Veerdonk. 2016. “When the Fight against Fungi Goes Wrong.” PLOS Pathogens 12 (2): e1005400.
193. Wi, Yu Mi. 2019. “Treatment of Extrapulmonary Nontuberculous Mycobacterial Diseases.” Infect Chemother 51 (3): 245–55.
194. Wolff, Dominik, Sarah Nee, Natalie Sandy Hickey, and Michael Marschollek. 2021. “Risk Factors for Covid-19 Severity and Fatality: A Structured Literature Review.” Infection 49 (1): 15–28.
195. World Health Organization. 2018. “WHO Seasonal Influenza.” https://www.who.int/news-room/fact-sheets/detail/influenza-(seasonal).
196. Xie, Yifan, Fenli Shao, Juan Lei, and Na Huang. 2022. “Case Report : A STAT1 Gain-of- Function Mutation Causes a Syndrome of Combined Immunode Fi Ciency , Autoimmunity and Pure Red Cell Aplasia,” no. August: 1–7.
197. Yan, Nan, and Zhijian J Chen. 2012. “Intrinsic Antiviral Immunity.” Nature Immunology 13 (3): 214–22.
198. Zhang, Qian, Zhiyong Liu, Marcela Moncada-Velez, Jie Chen, Masato Ogishi, Benedetta Bigio, Rui Yang, et al. 2020. “Inborn Errors of Type I IFN Immunity in Patients with Life-Threatening COVID-19.” Science 370 (6515).
199. Zhang, Shen-Ying, and Jean-Laurent Casanova. 2015. “Inborn Errors Underlying Herpes Simplex Encephalitis: From TLR3 to IRF3.” Journal of Experimental Medicine 212 (9): 1342–43.
200. Zhang, Shen Ying, Nathaniel E. Clark, Catherine A. Freije, Elodie Pauwels, Allison J. Taggart, Satoshi Okada, Hanna Mandel, et al. 2018. “Inborn Errors of RNA Lariat Metabolism in Humans with Brainstem Viral Infection.” Cell 172 (5): 952-965.e18.
201. Zhang, Wenjing, Xuemei Chen, Guodong Gao, Shubin Xing, Lina Zhou, Xuemei Tang, Xiaodong Zhao, and Yunfei An. 2021. “Clinical Relevance of Gain- and Loss-of-Function Germline Mutations in STAT1: A Systematic Review.” Frontiers in Immunology 12 (March): 1–14.
202. Zheng, Jie, Frank L. van de Veerdonk, Katherine L. Crossland, Sanne P. Smeekens, Chun M. Chan, Tariq Al Shehri, Mario Abinun, et al. 2015. “Gain-of-Function STAT1 Mutations Impair STAT3 Activity in Patients with Chronic Mucocutaneous Candidiasis (CMC).” European Journal of Immunology 45 (10): 2834–46.
203. Zheng, Ruijuan, Zhiqiang Li, Fusheng He, Haipeng Liu, Jianhua Chen, Jiayu Chen, Xuefeng Xie, et al. 2018. “Genome-Wide Association Study Identifies Two Risk Loci for Tuberculosis in Han Chinese.” Nature Communications 9 (1): 4072.
204. Zhou, Yunchun, Wei Mu, Jihua Zhang, Shi Wu Wen, and Smita Pakhale. 2022. “Global Prevalence of Non-Tuberculous Mycobacteria in Adults with Non-Cystic Fibrosis Bronchiectasis 2006–2021: A Systematic Review and Meta-Analysis.” BMJ Open 12 (8): e055672.
205. Zimmerman, Ofer, Peter Olbrich, Alexandra F. Freeman, Lindsey B. Rosen, Gulbu Uzel, Christa S. Zerbe, Sergio D. Rosenzweig, et al. 2019. “STAT1 Gain-of-Function Mutations Cause High Total STAT1 Levels with Normal Dephosphorylation.” Frontiers in Immunology 10 (JULY): 4–6.
206. Zimmerman, Ofer, Lindsey B. Rosen, Muthulekha Swamydas, Elise M.N. Ferre, Mukil Natarajan, Frank van de Veerdonk, Steven M. Holland, and Michail S. Lionakis. 2017. “Autoimmune Regulator Deficiency Results in a Decrease in STAT1 Levels in Human Monocytes.” Frontiers in Immunology 8 (JUL): 1–8.
207. Zimmermann, Natalie, Verena Thormann, Bo Hu, Anne-Britta Köhler, Aki Imai-Matsushima, Camille Locht, Eusondia Arnett, et al. 2016. “Human Isotype-Dependent Inhibitory Antibody Responses against Mycobacterium Tuberculosis.” EMBO Molecular Medicine 8 (11): 1325–39.